The Forsyth Institute Inc.Non-Profit

Finding 2020-001: Reporting Federal Programs Department of Health and Human Services Research and Development Cluster Contract # / Description R01DE024308 Physiological Interaction Between Probiotic Bacteria & Porphyromonas gingivalis R01DE023838 Regulation & Function of Interleukin-7 in Primary Sjogrens Syndrome R01DE024468 Cultivation, Nature, Ecology & Pathogenicity of the Uncultivable Oral Microbiom R01DE025020 Mechanisms of Resolvin E1 in Periodontal Regeneration R01DE025255 Regulatory B cells in the amelioration of immune-mediated periodontal disease R01GM117174 Impact of commensal Corynebacterium species R01DE025865 Enamel matrix 3D organization & maturation stage ion flow R37DE016937 A Foundation for the Oral Microbiome and Metagenome R01AI101018 Antibiotics from nose and throat commensals R01DE027249 Novel Recombinant Streptococcus R90DE027638 Forsyth Postdoctoral Training in Oral Health Research T90DE026110 Forsyth Postdoctoral Training in Oral Health Research K99DE027719 Molecular & pathogenic study of an oral TM7 strain R01DE022586 Spatial Organization of the Oral Microbiome R21DE026874 Saliva-mediated Mechanisms in Post-Eruptive Enamel Mineralization R21DE026872 Bayesian multivariate image analysis R01DE026186 Studying the Protective Effects of Normal Oral Flora R01DE020102 Making a quantum leap in plaque research with modern sciences R03DE027486 Multivariate Bayesian variable selection for oral microbiome data R21EY028209 Infections of specific periodontal microbiota R03DE028033 The Role of Plasmacytoid Dentdritic Cells in the Pathogenesis of Sjogrens R01DE023810 Domestication & characterization of TM7-the most elusive oral phylum R03AI142273 Role of Interleukin-22 in Salivary Gland Disorder in Autoimmune SS R21DE029003 Regulation of salivary gland inflammation in SS by Annexin 1 R00DE027719 Molecular & pathogenic study of an oral TM7 strain R03DE029273 What gives the dentin-enamel junction strength Criteria or Specific Requirement: Pursuant to the CFR 200.328, organizations must submit performance reports at the interval required by the Federal awarding agency or pass-through entity to best inform improvements in program outcomes and productivity. Intervals must be no less frequent than annually nor more frequent than quarterly except in unusual circumstances, for example where more frequent reporting is necessary for the effective monitoring of the Federal award or could significantly affect program outcomes. Annual reports must be due 90 calendar days after the reporting period; quarterly or semiannual reports must be due 30 calendar days after the reporting period. Alternatively, the Federal awarding agency or pass-through entity may require annual reports before the anniversary dates of multiple year Federal awards. The final performance report will be due 90 calendar days after the period of performance end date. Condition: During our testing we identified an instance where the Institute filed a required report past the submission deadline. Context: We noted that the third quarter (9/30/19) report due to the National Institutes of Health was filed four days after the submission deadline. Cause: Due to staff turnover there was a miscommunication of responsibilities between the research and finance departments Effect: The third quarter report due to the National Institutes of Health was filed late. Questioned Costs: None Recommendation: We recommend that the Institute ensure responsibilities for filing of required reports are communicated to the appropriate individuals. Views of Responsible Officials: Refer to Corrective Action Plan.